Genetic Financial Statements From 2010 to 2025

Stocks . Australia . 
Stock . Genetic Signatures
GSS Stock   0.24  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Genetic Signatures' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genetic Signatures' valuation are summarized below:
Gross Profit
10.5 M
Profit Margin
(1.02)
Market Capitalization
54.5 M
Enterprise Value Revenue
1.51
Revenue
19.8 M
There are currently eighty-four fundamental trends for Genetic Signatures that can be evaluated and compared over time across competitors. All traders should confirm Genetic Signatures' regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Genetic Signatures Total Revenue

10.98 Million

Check Genetic Signatures financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genetic Signatures' main balance sheet or income statement drivers, such as Interest Expense of 95.5 K, Selling General Administrative of 16.9 M or Total Revenue of 11 M, as well as many indicators such as . Genetic financial statements analysis is a perfect complement when working with Genetic Signatures Valuation or Volatility modules.
  
This module can also supplement various Genetic Signatures Technical models . Check out the analysis of Genetic Signatures Correlation against competitors.

Genetic Signatures Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets34.7 M54.6 M27.9 M
Slightly volatile
Short and Long Term Debt Total897.2 K791 K1.3 M
Slightly volatile
Other Current Liabilities1.1 M840 K888.5 K
Slightly volatile
Total Current Liabilities2.9 M4.1 M2.4 M
Slightly volatile
Other Liabilities114.7 K109.2 K41.7 K
Slightly volatile
Property Plant And Equipment Net3.8 M6.7 M3 M
Slightly volatile
Accounts Payable1.7 M2.4 M1.4 M
Slightly volatile
Cash7.1 M7.5 M13.6 M
Slightly volatile
Non Current Assets Total4.9 M6.7 M4 M
Slightly volatile
Long Term Debt3.1 M3.5 M3.9 M
Slightly volatile
Cash And Short Term Investments19.8 M31.3 M15.9 M
Slightly volatile
Net Receivables4 M3.4 M3.2 M
Slightly volatile
Common Stock Shares Outstanding126.3 M226.7 M104.4 M
Slightly volatile
Liabilities And Stockholders Equity34.7 M54.6 M27.9 M
Slightly volatile
Non Current Liabilities Total373.8 K437 K898.5 K
Slightly volatile
Total Liabilities3.5 M4.5 M3.3 M
Slightly volatile
Total Current Assets29.8 M48 M23.9 M
Slightly volatile
Common Stock71.7 M127.6 M59.7 M
Slightly volatile
Property Plant Equipment3.8 M6.7 M3 M
Slightly volatile
Net Tangible Assets26.4 M43 M22.2 M
Slightly volatile
Common Stock Total Equity51.7 M96.6 M58.2 M
Slightly volatile
Property Plant And Equipment Gross16.3 M15.5 M5.7 M
Slightly volatile
Inventory5.8 M9.1 M4.1 M
Slightly volatile
Net Invested Capital42.1 M50.1 M30.1 M
Slightly volatile
Cash And Equivalents7.6 M5.7 M9.5 M
Slightly volatile
Net Working Capital35.4 M43.9 M25.8 M
Slightly volatile
Capital Stock99.2 M127.6 M69.2 M
Slightly volatile
Short Term Investments24.1 M23.8 M18.1 M
Slightly volatile
Capital Lease Obligations700.9 K791 K736.1 K
Very volatile
Other Assets0.80.90.9813
Slightly volatile

Genetic Signatures Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative16.9 M16.1 M3.7 M
Slightly volatile
Total Revenue11 M15.9 M9.4 M
Slightly volatile
Cost Of Revenue9.3 M8.1 M8 M
Slightly volatile
Depreciation And Amortization2.5 M2.4 M927 K
Slightly volatile
Selling And Marketing Expenses1.9 M1.2 M2.2 M
Pretty Stable
Other Operating Expenses18.4 M34.4 M15.1 M
Slightly volatile
Total Operating Expenses27.6 M26.3 M8.3 M
Slightly volatile
Interest Income1.7 M1.6 M277.5 K
Slightly volatile
Reconciled Depreciation1.4 M2.4 M981.2 K
Slightly volatile

Genetic Signatures Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures856.9 K902 K1.8 M
Slightly volatile
Stock Based Compensation2.4 M2.3 M996.7 K
Slightly volatile
Depreciation2.4 M2.3 M912.9 K
Slightly volatile
End Period Cash Flow7.1 M7.5 M12.8 M
Slightly volatile
Begin Period Cash Flow38.1 M36.3 M14.2 M
Slightly volatile
Change To Netincome2.7 M2.6 M1 M
Slightly volatile
Issuance Of Capital Stock13.5 M8.8 M6.3 M
Slightly volatile
Dividends Paid20.5 K21.6 K21.8 M
Slightly volatile

Genetic Fundamental Market Drivers

Forward Price Earnings54.9451
Cash And Short Term Investments31.3 M

About Genetic Signatures Financial Statements

Genetic Signatures shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Genetic Signatures investors may analyze each financial statement separately, they are all interrelated. The changes in Genetic Signatures' assets and liabilities, for example, are also reflected in the revenues and expenses on on Genetic Signatures' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue764.8 K803 K
Total Revenue15.9 M11 M
Cost Of Revenue8.1 M9.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genetic Stock Analysis

When running Genetic Signatures' price analysis, check to measure Genetic Signatures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Signatures is operating at the current time. Most of Genetic Signatures' value examination focuses on studying past and present price action to predict the probability of Genetic Signatures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Signatures' price. Additionally, you may evaluate how the addition of Genetic Signatures to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY